U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 2) by stretch611 on Wednesday January 23 2019, @05:11PM
Or using enough of those profits to line our congress critter's pockets to look the other way.
Drug industry price increases (and healthcare in general, as well as insulin costs) have far exceeded inflation for more years than I remember.
As I mentioned [soylentnews.org] on a previous diabetes article [soylentnews.org].
Now with 5 covid vaccine shots/boosters altering my DNA :P